Litcius/Paper detail

Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial

Katherine Gill, Leigh F. Johnson, Janan Dietrich, Landon Myer, Rebecca Marcus, Melissa Wallace, Tanya Pidwell, Eve Mendel, Lauren Fynn, Kai A. Jones, Lubbe Wiesner, Catherine Slack, Ann Strode, Hans Spiegel, Sybil Hosek, James F. Rooney, Glenda Gray, Linda‐Gail Bekker

2020The Lancet Child & Adolescent Health65 citationsDOIOpen Access PDF

Topics & Concepts

MedicineEmtricitabinePre-exposure prophylaxisPopulationIncidence (geometry)Human immunodeficiency virus (HIV)Family medicineEnvironmental healthAntiretroviral therapyMen who have sex with menViral loadOpticsPhysicsSyphilisHIV/AIDS Research and InterventionsAdolescent Sexual and Reproductive HealthMobile Health and mHealth Applications
Acceptability, safety, and patterns of use of oral tenofovir disoproxil fumarate and emtricitabine for HIV pre-exposure prophylaxis in South African adolescents: an open-label single-arm phase 2 trial | Litcius